Cargando…
Optimization and Anti-Cancer Properties of Fluoromethylketones as Covalent Inhibitors for Ubiquitin C-Terminal Hydrolase L1
The deubiquitinating enzyme (DUB) UCHL1 is implicated in various disease states including neurodegenerative disease and cancer. However, there is a lack of quality probe molecules to gain a better understanding on UCHL1 biology. To this end a study was carried out to fully characterize and optimize...
Autores principales: | Krabill, Aaron D., Chen, Hao, Hussain, Sajjad, Hewitt, Chad S., Imhoff, Ryan D., Muli, Christine S., Das, Chittaranjan, Galardy, Paul J., Wendt, Michael K., Flaherty, Daniel P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7956625/ https://www.ncbi.nlm.nih.gov/pubmed/33668938 http://dx.doi.org/10.3390/molecules26051227 |
Ejemplares similares
-
Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3
por: Hewitt, Chad S., et al.
Publicado: (2022) -
Ubiquitin C-Terminal Hydrolase L1 in Tumorigenesis
por: Hurst-Kennedy, Jennifer, et al.
Publicado: (2012) -
Characterization of the Ubiquitin C-Terminal Hydrolase and Ubiquitin-Specific Protease Families in Rice (Oryza sativa)
por: Wang, Dong-Hui, et al.
Publicado: (2018) -
Drosophila Ubiquitin C-Terminal Hydrolase Knockdown Model of Parkinson’s Disease
por: Tran, Hiep H., et al.
Publicado: (2018) -
Ubiquitin Carboxyl-Terminal Hydrolases (UCHs): Potential Mediators for Cancer and Neurodegeneration
por: Sharma, Amit, et al.
Publicado: (2020)